Sotera Health Company Profile Avatar - Palmy Investing

Sotera Health Company

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Lab…
Medical - Diagnostics & Research
US, Broadview Heights [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 17% Weak
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 32.37 3.20 2.42
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 69.76 20.70 12.19
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -3.43 1.52 1.58
Cash -13.12 0.93 1.07
Capex 46.29 -0.12 -0.23
Free Cash Flow -45.28 -0.09 0.17
Revenue -20.17 0.88 1.10
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -15.30 0.45 0.53
Operating Margin -40.26 0.24 0.40
ROA -83.28 < 0.005 0.01
ROE -83.11 0.01 0.09
ROIC -53.05 0.01 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of SHC is permitted for members.
5 Growth
The "Growth Entry" for the Focus of SHC is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of SHC is permitted for members.
End of SHC's Analysis
CIK: 1822479 CUSIP: 83601L102 ISIN: US83601L1026 LEI: - UEI: -
Secondary Listings
SHC has no secondary listings inside our databases.